Market Analysis: Europe Drug Screening Market
Europe drug screening market is registering a substantial CAGR in the forecast period of 2019-2026. This growth in market value can be attributed to the increasing awareness and knowledge about people's health.
Market Definition: Europe Drug Screening Market
Drug testing is used to identify prescription drugs as well as illicit drugs in semen, plasma, and other biological samples, especially in clinics, offices, athletes, colleges. It is known to be a vital part of ongoing diagnosis and treatment, either intentionally or at random. Generally, drug screening takes place before a job or sports activity. Some of them are methamphetamine, opium, amphetamine and hemp, along with modern psychoactive substances such as phenethylamines, ketamine, and piperazine, which are on the drug market.
Get More Insights About Europe Drug Screening Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-drug-screening-market
Market Drivers
• Regulatory licenses and product launches and products, drives the market growth
• Rising government funding, is expected to drive the market growth
• Increasing alcohol and drug consumption, drives the market growth
• Implementation of specific laws requiring drugs and alcohol control, drives the market growth
Market Restraints
• Ban on alcohol in several countries, restrain the growth of market
• Legalization for drug testing in the workplaces, hampering the market growth
• Accurateness of breathalyzer, hindering the growth of market
Segmentation: Europe Drug Screening Market
By Products and Services
• Analytical Instruments
 Immunoassay Analyzers
 Chromatography Instruments
 Breath Analyzers
• Fuel Cell Breathalyzers
• Semiconductor Breathalyzers
• Other Devices
• Rapid Testing Devices
 Urine Testing Devices
• Urine Testing Cups
• Dip Cards
• Cassettes
o Oral Fluid Testing Devices
Consumables
o Assay Kits
o Sample Collection Cups
o Calibrators and Controls
o Others
Drug Screening Services
By Sample Type
• Urine
• Breath
• Saliva
• Hair
• Blood
• Skin
• Oral Fluid
• Others
By Condition
• Unconsciousness
• Panic Attack
• Chest Pain
• Drug Allergies
• Breathing Problem
• Seizures
• Organ Transplant
• Pain Management
• Others
By End User
• Workplace and Schools
• Drug Testing Laboratories
• Criminal Justice System & Law Enforcement Agencies
• Hospitals
• Drug Treatment Centers
• Pain Management Centers
• Personal Users
By Country
• Germany
• Italy
• U.K.
• France
• Spain
• Netherlands
• Belgium
• Switzerland
• Turkey
• Russia
• Rest of Europe
Know more about this report https://www.databridgemarketresearch.com/reports/europe-drug-screening-market
Key Developments in the Market:
• In July 2019, InSphero AG declared the launch of its 3D InSight Human Liver Disease Discovery Platform for non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD). This platform has been specifically designed to include all types of human liver cells and inducers required to reproduce NASH development in patients, from fatty liver (steatosis) to inflammation (NASH) and liver scarring (fibrosis). With the release of this product, company will extend its product portfolio as well as its market size.
• In August 2017, SYNLAB International GmbH, a prominent supplier of medical diagnostic services in Europe has acquired Lextox based in Cardiff. The company is an ISO17025 UKAS certified, specialized in alcohol and hair drugs testing, supplemented by a wide range of blood testing and DNA facilities. This acquisition will extend business growth and its product portfolio that will increase sales and revenue of the company.
Competitive Analysis:
Drug screening market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of drug screening market for Europe.
Get Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/europe-drug-screening-market
Key Market Competitors:
Few of the major market competitors currently working in the Europe drug screening market are Quest Diagnostics Incorporated, MPD, Inc., Abbott, Drägerwerk AG & Co. KGaA, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Shimadzu Corporation, Psychemedics Corporation, Boehringer Ingelheim International GmbH, Bayer AG, AstraZeneca, Sanofi, Pfizer Inc. GlaxoSmithKline plc., Merck & Co., Inc., and Novartis AG among others.
Primary Respondents
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others
Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=europe-drug-screening-market
Browse Trending Related Reports @
• Aromatase Inhibitors Market
• Autoimmune Hemolytic Anemia Treatment Market
• Pharmaceuticals Packaging Testing Equipment Market
• Organ Transplant Immunosuppressant Drugs Market
• Medical Gas Market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]